TAU-2014-1: Mibefradil and Hypofractionated Re-Irradiation Therapy in Recurrent GBM

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02202993
Recruitment Status : Completed
First Posted : July 29, 2014
Last Update Posted : March 31, 2017
Yale University
Information provided by (Responsible Party):
Cavion, Inc.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 31, 2017
  Actual Study Completion Date : March 31, 2017